Cargando…
Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
The COVID-19 pandemic of 2020 and its' accompanied lockdowns impacted the entire globe in ways the world is only beginning to comprehend. In Israel, children age 9–15 had not been in a frontal classroom and been socially restricted from March 2020 till March 2021. Fourteen of these children tha...
Autores principales: | Erdinest, Nir, London, Naomi, Levinger, Nadav, Lavy, Itay, Pras, Eran, Morad, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Contact Lens Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278875/ https://www.ncbi.nlm.nih.gov/pubmed/34238687 http://dx.doi.org/10.1016/j.clae.2021.101475 |
Ejemplares similares
-
Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study
por: Erdinest, Nir, et al.
Publicado: (2022) -
Treatment of Rapid Progression of Myopia: Case Series and Literature Review
por: Erdinest, Nir, et al.
Publicado: (2021) -
Low-Concentration Atropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses for Myopia Management
por: Erdinest, Nir, et al.
Publicado: (2022) -
Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series
por: Erdinest, Nir, et al.
Publicado: (2021) -
Peripheral Defocus and Myopia Management: A Mini-Review
por: Erdinest, Nir, et al.
Publicado: (2023)